{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"0.365","rs_stock_flag":false,"fiscal_year_end":"2024年12月31日","hist_closedate":"2025年9月25日","replication_method":null,"amt_os":"1,401,358,800","primaryexch":"香港交易所","ric":"2297.HK","product_subtype":null,"db_updatetime":"2025年9月28日08:06","mkt_cap_u":"M","am_u":"K","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":0.0,"inline_upper_strike_price":"","sedol":"BM8GFB9","am":"325.05","iv":"","ew_strike":"","as":"0.360","geographic_focus":null,"incorpin":"開曼群島","etp_baseCur":null,"ew_amt_os":"","bd":"0.350","registrar":"卓佳證券登記有限公司","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"1,000","update_time":"2025-09-28 00:06:03.0","lo52":"0.128","shares_issued_date":"2025年8月31日","premium":"","strike_price_ccy":null,"yield":"","vo_u":"K","base_currency":null,"coupon":"","expiry_date":"","chairman":"霍雲飛","underlying_ric":"2297.HK","hi52":"0.700","issuer_name":"潤邁德醫療有限公司 - B","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"2025年9月26日16:08","aum_date":"","lo":"0.345","mkt_cap":"504.48","f_aum_hkd":null,"ew_sub_per_to":"","ls":"0.360","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"醫療保健業 - 其他醫療保健","ew_desc":null,"inception_date":"","nc":"0.000","aum":"","issued_shares_class_B":null,"vo":"926.00","secondary_listing_flag":false,"listing_date":"2022年7月8日","issued_shares_class_A":null,"as_at_label":"截至","ew_amt_os_dat":"","nm":"潤邁德醫療有限公司 - B","nm_s":"潤邁德－Ｂ","sym":"2297","inline_lower_strike_price":"","listing_category":"主要上市","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.005","strike_price":"","summary":"潤邁德醫療有限公司是一家投資控股公司。該公司主要從事與基于冠狀動脈造影的血流儲備分數係統（caFFR系統）及基于冠狀動脈造影的微血管阻力指數係統（caIMR系統）相關的醫療器械的研發、製造及商業化。該公司的核心產品（即caFFR系統及caIMR系統）是創新的醫療器械，用於評估冠狀動脈狹窄和微血管功能障礙（冠狀動脈疾病（CAD）的相關起因）引起的心肌缺血的嚴重程度，其設計旨在替代壓力導絲的使用，大幅減少技術誤差和操作時間，從而改善生理評估。該公司主要在中國國內和海外市場開展業務。","op":"0.350","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"醫療設備及用品","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"香港太古<br/>太古灣道14號<br/>太古城中心三期<br/>19樓19–108室","pc":"0.00","days_to_expiry":null,"underlying_code":null,"pe":"","eps_ccy":"RMB","hdr":false,"launch_date":"","hc":"0.360","isin":"KYG7360A1094","moneyness":""}},"qid":"1759074865254"}
